Abiopharma

New Form EFFECT - Autonomix Medical, Inc. Filed: 2025-09-08 AccNo: 9999999995-25-002872 Size: 1 KB

General Announcement: DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS): DEALINGS OUTSIDE CLOSED PERIOD

TRML Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Tourmaline Bio, Inc. Is Fair to Shareholders

General Announcement: CHANGES IN SUBSTANTIAL SHAREHOLDERS INTEREST PURSUANT TO SECTION 138 OF THE COMPANIES ACT 2016

Autonomix Medical, Inc. Announces Abstract Accepted for Podium Presentation at the 2025 CIRSE Annual Congress

FDA approve PHYTONADIONE

FDA approve FUROSEMIDE

NASDAQ symbol attribute type Security_Name was changed. Previous value: Renovaro Inc. - Common Stock. New value: Lunai Bioworks Inc. - Common Stock.

Shareholder Alert: The Ademi Firm investigates whether Tourmaline Bio, Inc. is obtaining a Fair Price for its Public Shareholders

Best Cheap Air Fryers for Healthy Cooking in 2025

Best Budget Cheap Gaming Mouse Options

Best Budget Mirrorless Cameras for Photography Beginners (2025)

Best Budget Soundbars for Enhanced Home Audio (2025)

Best Budget Wireless Headphones

Tourmaline Bio Enters into Agreement to be Acquired by Novartis AG